U.S. FDA approves first nasal spray to treat dangerous allergic reactions

The Food and Drug Administration said it approved the spray from drugmaker ARS Pharmaceuticals Inc. as an emergency treatment for anaphylaxis; this is the first needle-free alternative to injectable products like EpiPen